0001213900-24-054781.txt : 20240621 0001213900-24-054781.hdr.sgml : 20240621 20240621161523 ACCESSION NUMBER: 0001213900-24-054781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240621 FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gabay Avraham CENTRAL INDEX KEY: 0001777328 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35813 FILM NUMBER: 241060355 MAIL ADDRESS: STREET 1: 2/4 HIGH-TECH PARK, P.O. BOX 39098 CITY: JERUSALEM STATE: L3 ZIP: 91390 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001176309 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980376008 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-844-1164 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Integrated Security Technologies, Inc. DATE OF NAME CHANGE: 20040614 FORMER COMPANY: FORMER CONFORMED NAME: IGUANA VENTURES LTD DATE OF NAME CHANGE: 20020625 4 1 ownership.xml X0508 4 2024-06-21 0 0001176309 ORAMED PHARMACEUTICALS INC. ORMP 0001777328 Gabay Avraham 1185 AVENUE OF THE AMERICAS, THIRD FLOOR NEW YORK NY 10036 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-06-21 4 A 0 140040 A 0 D Represents a grant of 140,040 Restricted Stock Units ("RSUs"), of which 93,360 will vest on June 18, 2026 and the remaining 46,680 will vest in four equal quarterly installments of 11,670 starting September 18, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. /s/ Avraham Gabay 2024-06-21